Intimate Rose Pelvic Wand (Purple); Intimate Rose Bendable Pelvic Wand (Orange); Intimate Rose Temperature Pelvic Wand (Yellow)

K250419 · Plus EV Holdings, Inc. D/B/A Intimate Rose · OSD · Jul 27, 2026 · Physical Medicine

Device Facts

Record IDK250419
Device NameIntimate Rose Pelvic Wand (Purple); Intimate Rose Bendable Pelvic Wand (Orange); Intimate Rose Temperature Pelvic Wand (Yellow)
ApplicantPlus EV Holdings, Inc. D/B/A Intimate Rose
Product CodeOSD · Physical Medicine
Decision DateJul 27, 2026
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 890.5670
Device ClassClass 2

Regulatory Classification

Identification

A hand-held internal therapeutic massager device is a prescription device intended for medical purposes to manually provide direct pressure applied to localized areas of pain or tenderness in the myofascial tissue associated with chronic pelvic pain syndromes. The device is inserted rectally or vaginally and provides quantitative feedback to the user of the applied force to the target tissue.

Special Controls

In combination with the general controls of the FD&C Act, the AHIP Internal Trigger Point Wand is subject to the following special controls: - 1. The labeling must include adequate directions for use, including prescribing information, to ensure safe and effective use by the patient; - 2. Appropriate analysis/testing must validate electromagnetic compatibility (EMC), electrical safety and mechanical safety; - 3. Non-clinical performance testing must demonstrate a reasonable assurance of safety and effectiveness. including mechanical durability and accurate feedback mechanism: - 4. Appropriate software verification, validation, and hazard analysis must be performed: and - 5. All elements of the device that may contact the patient must be demonstrated to be biocompatible.

*Classification.* Class II (special controls). The device, when it is for prescription use only with a quantitative feedback mechanism and a disposable covering, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9. The special controls for this device are:(1) Labeling must include adequate directions for use. (2) Non-clinical performance testing must demonstrate electromagnetic compatibility (EMC), electrical safety and mechanical safety. (3) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use. The following performance characteristics must be tested: (i) Mechanical durability; and (ii) Accuracy of the feedback mechanism. (4) Software verification, validation, and hazard analysis must be performed. (5) The patient-contacting components of the device must be demonstrated to be biocompatible.

Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...